About us
The T-cell Project 2.0 is a prospective, longitudinal, international, observational study of patients with histological diagnosis of Peripheral T-cell lymphoma. The purpose of the present study is to verify whether a prospective collection of data would allow more accurate information on T-cell lymphomas to be achieved. In particular, to better define the clinical relevance of the new WHO Classification, the role of FDG-PET in staging and response assessment, the prognosis of different entities, the genomic landscape of different subtypes, and to investigate on most adequate treatment strategies for these neoplasms in the real-world population.
EXECUTIVE COMMITTEE
- Massimo Federico, MD – Study Coordinator
University of Modena and Reggio Emilia
Centro Oncologico Modenese, Modena, Italy
massimo.federico@unimore.it
+39 0594225515 - Attilio Guarini, MD – Study Coordinator
U.O. Ematologia
IRCCS Istituto Tumori “Giovanni Paolo II”
attilioguarini@oncologico.bari.it
+39 0805555391 - Julie Vose, MD
Section of Hematology/Oncology
Nebraska Medical Center, USA
jmvose@unmc.edu
(402) 559-3848 - Steven Horwitz, MD
Memorial Sloan-Kettering Cancer Center
New York, NY, USA
horwitzs@mskcc.org
(212) 639-3045 - Miles Prince, MD
Peter MacCallum Cancer Centre
Melbourne, Australia
Miles.Prince@petermac.org
+61 3 85604010 - Kim Won Seog, MD
Hematology-Oncology Samsung Medical Center
Seoul, South Korea
wskimsmc@skku.edu - Dolores Caballero, MD
Instituto Biosanitario de Salamanca
Salamanca, Spain
cabarri@usal.es
34 923 291 384 - Francesco Zaya, MD
Azienda Sanitaria Universitaria Integrata S. M. Misericordia
Udine, Italy
zaja.francesco@aoud.sanita.fvg.it
+ 39 0432 559604 - Stefano Luminari, MD
S.C. Ematologia, Arcispedale S. Maria Nuova-IRCCS
Reggio Emilia, Italy
stefano.luminari@unimore.it
+39 0522 296119 - Ranjana Advani, MD
Stanford University Medical Center
Stanford, CA, USA
radvani@stanford.edu
+1 650-498-6000 - Pierluigi Porcu, MD
Hematopoietic Stem Cell Transplantation
Sidney Kimmel Cancer Center, USA
Pierluigi.Porcu@jefferson.edu
215-503-7787 - Astrid Pavlovsky, MD
Centro de Hematología
FUNDALEU, Buenos Aires, Argentina
astridp@intramed.ne - Carlos Chiattone, MD
Departamento de Clínica Médica
FCM da Santa Casa de Sao Paulo, Sao Paulo, Brazil
carlos.chiattone@terra.com.br
(11) 2506-9053 - Francine Foss, MD
Yale University School of Medicine
New Haven, CT, USA
francine.foss@yale.edu
+1 203-200-4363 - Christopher Fox, MD
Clinical Haematology, Nottingham University Hospitals NHS Trust
Nottingham, UK
christopher.fox@nhs.net
+44 115 969 1169
HISTOPATHOLOGY REVIEW PANEL
- Stefano Pileri, MD
Istituto Europeo di Oncologia, Milano, Italy and Università degli Studi di Bologna, Bologna, Italy
stefano.pileri@ieo.it
+39 02 57489.770 - John Chan, MD
Department of Pathology, City of Hope Medical Center, Duarte, CA
jochan@coh.org
800-826-4673 - Eric Hsi, MD
Department of Pathology, University Hospitals, Cleveland, OH, USA
HSIE@ccf.org
216-444-5230 - Miguel A Piris, MD
Pathology Department, Fundacion Jiménez Diaz, UAM
Madrid, Spain
miguel.piris@quironsalud.es
34 91 550 4804 - Young-Hyeh Ko, MD
Department of Pathology, Samsung Medical Centre, Sungkyunkwan
University School of Medicine, Seoul, South Korea
yhko310@skku.edu
82-2-3410-2752
TRIAL OFFICE
DATA MANAGEMENT, MONITORING AND COMPLIANCE
- Martina Manni, PhD
University of Modena and Reggio Emilia, Italy
marmanni@unimore.it
+30 0594223284
+39 0594223707 - Monica Civallero, PhD
University of Modena and Reggio Emilia, Italy
monica.civallero@unimore.it
+39 0594223475
+39 0594223707 - Athina Lymboussakis, PhD
University of Modena and Reggio Emilia, Italy
athina.lymboussakis@unimore.it
+39 0594223143
+39 0594223707
SOFTWARE DEVELOPMENT AND ADMINISTRATION
- Enrico Calanchi & Mirko Orsini, Software Engineers
DataRiver Srl
Via Vignolese, 905
41125 Modena – Italy
+39.059.205 6395
info@datariver.it